scanX
Home
Bharat Immunologicals

Bharat Immunologicals

23.58
+0.37
(1.59%)
Market Cap (₹ Cr.)
₹100
52 Week High
43.89
Book Value
₹
52 Week Low
22.25
PE Ratio
PB Ratio
-3.08
PE for Sector
49.68
PB for Sector
19.95
ROE
-19.43 %
ROCE
-16.78 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-40.38 %
Net Income Growth
94.32 %
Cash Flow Change
125.85 %
ROE
133.81 %
ROCE
357.22 %
EBITDA Margin (Avg.)
577.05 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Revenue
24
17
14
39
59
28
11
24
62
4
6
5
22
0
5
8
73
9
8
29
22
19
26
26
25
15
25
18
23
11
27
0
8
0
0
Expenses
27
21
17
39
57
28
9
22
55
5
8
4
26
2
8
8
75
13
15
31
19
19
30
28
32
13
28
16
26
15
29
5
12
4
5
EBITDA
-3
-4
-3
0
2
-0
3
3
7
-2
-2
1
-4
-1
-4
1
-2
-4
-7
-2
3
0
-4
-1
-7
1
-3
1
-3
-5
-2
-5
-4
-4
-5
Operating Profit %
-15 %
-26 %
-28 %
1 %
3 %
-2 %
22 %
10 %
11 %
-62 %
-44 %
5 %
-20 %
-1,600 %
-77 %
6 %
-6 %
-82 %
-83 %
-7 %
17 %
3 %
-18 %
-9 %
-102 %
7 %
-14 %
6 %
-17 %
-46 %
-9 %
0 %
-53 %
0 %
0 %
Depreciation
0
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
1
1
0
0
1
1
0
0
0
0
0
0
0
1
1
1
2
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
Profit Before Tax
-4
-4
-4
-1
1
-1
3
2
6
-2
-2
0
-4
-1
-4
0
-3
-5
-8
-3
2
-1
-6
-2
-8
0
-5
-0
-5
-6
-4
-6
-6
-6
-7
Tax
-1
-1
-0
-0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-2
-3
-4
-1
1
-0
2
2
4
-1
-2
1
-1
-1
-3
0
-2
-4
-6
-2
4
-1
-4
-2
-7
2
-9
-0
-4
-5
-3
-5
-4
-5
-5
EPS in ₹
-0.52
-0.73
-0.57
-0.16
0.22
-0.09
0.36
0.51
0.95
-0.31
-0.55
0.12
-0.30
-0.19
-0.58
0.00
-0.52
-0.80
-1.28
-0.54
0.87
-0.18
-0.90
-0.44
-1.51
0.45
-2.17
-0.08
-0.99
-1.16
-0.71
-1.08
-0.90
-1.06
-1.14
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Assets
80
68
59
53
125
127
104
213
186
Fixed Assets
6
6
5
5
5
5
4
116
115
Current Assets
74
60
47
38
99
93
34
65
33
Capital Work in Progress
0
0
0
0
0
0
32
0
0
Investments
0
0
0
0
0
0
0
0
0
Other Assets
74
63
53
48
120
122
68
97
70
Total Liabilities
80
68
59
53
125
127
104
213
186
Current Liabilities
35
30
14
13
89
101
64
101
91
Non Current Liabilities
4
3
3
3
6
6
6
6
6
Total Equity
41
35
42
38
31
21
34
105
88
Reserve & Surplus
-2
-8
-1
-6
-13
-23
-9
62
45
Share Capital
43
43
43
43
43
43
43
43
43
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Cash Flow
7
-10
-20
1
-1
1
0
3
-3
Investing Activities
0
1
1
-1
1
1
1
1
1
Operating Activities
8
-9
-17
3
-32
34
12
-42
11
Financing Activities
-1
-2
-3
-1
31
-34
-12
45
-15
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Promoter
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
59.25 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
37.32 %
37.50 %
38.51 %
39.58 %
38.77 %
39.15 %
39.11 %
38.86 %
38.97 %
39.13 %
39.30 %
39.35 %
39.47 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,421.35 1,15,052.80 66.15 10,785.70 11.59 1,656 17.36 60.00
Gland Pharma
1,824.35 29,316.70 42.40 5,835.00 50.97 773 -15.77 59.49
Eris Lifesciences
1,353.10 18,265.50 52.44 2,033.00 19.85 397 -21.26 39.79
Caplin Point Laboratories
2,399.10 18,221.10 36.94 1,761.00 15.65 461 12.66 60.93
Sai Life Sciences
746.05 15,870.60 191.85 1,494.30 20.01 83 - -
Marksans Pharma
290.20 13,313.10 38.34 2,227.80 16.55 315 16.71 36.40
Shilpa Medicare
765.35 7,497.10 130.49 1,159.80 8.65 32 1,018.75 33.67
Jeena Sikho Lifecare
2,163.35 5,615.20 168.18 207.30 40.07 34 - 51.59
Ajanta Pharma
2,790.90 3,325.80 39.99 4,293.30 11.77 816 10.86 38.75
Windlas Biotech
1,048.75 2,156.10 35.28 644.40 23.21 58 12.14 50.41

Corporate Action

Technical Indicators

RSI(14)
Neutral
40.17
ATR(14)
Less Volatile
1.02
STOCH(9,6)
Oversold
13.38
STOCH RSI(14)
Oversold
8.99
MACD(12,26)
Bearish
-0.20
ADX(14)
Weak Trend
24.23
UO(9)
Bearish
38.15
ROC(12)
Downtrend But Slowing Down
-7.46
WillR(14)
Oversold
-83.25
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.